Pricing

from $24.00 / 1,000 processed market catalysts

Market Catalyst Signal Extractor

Extract market-moving catalyst signals from public news and finance-result pages for tickers, companies, sectors, and watchlist topics.

Pricing

from $24.00 / 1,000 processed market catalysts

Rating

0.0

(0)

Developer

Ushba Khan

Actor stats

Bookmarked

Total users

Monthly active users

3 days ago

Last modified

Market Catalyst Watchlist

glowing_glove/market-catalyst-watchlist

Monitor listed companies for fresh catalyst signals, filing activity, earnings timing, and source-backed market-watch rows.

Ushba Khan

Stock Catalyst News Scraper

seeb/stock-catalyst-radar

Scrape public market-news signals and return company names, ticker clues, catalyst summaries, source URLs, timestamps, and opportunity scoring.

Techionik

Stock Market Catalyst Scraper

seeb/market-catalyst-watchlist

Find public stock catalyst signals from news-style sources and return ticker mentions, event summaries, links, timing, and research-ready scoring.

Techionik

Harvard Catalyst Profiles Scraper

futurizerush/harvard-catalyst-profiles-scraper

Extracts researcher contact details from the Harvard Catalyst Profiles directory.

Rush

5.0

Stock Catalyst Scraper - Filing & News Signals

seeb/stock-catalyst-scraper

Scrape public-company catalysts from filings, earnings dates, press releases, and source pages with urgency scoring.

Techionik

Biotech Catalyst Monitor: Clinical Trial Readouts & Signals

datasignalslab/biotech-catalyst-monitor

Biotech catalyst monitor: upcoming trial readouts and phase changes from ClinicalTrials.gov, scored on price impact. Pay per company.

DataSignals Lab

Catalyst Calendar — earnings, IPO & lockup dates

brandon_nava/catalyst-calendar

Provenance-stamped US-equity catalyst calendar for AI agents: upcoming earnings, IPOs, and computed lockup expiries. Every row cites its primary source.

Brandon Nava

Clinical Catalyst Radar for Biotech

scrapemint/clinical-catalyst-pipeline

For each biotech company, correlates clinical pipeline progress (ClinicalTrials.gov) and research momentum (PubMed) with open-market insider buying (SEC Form 4), scores convergence 0 to 100, and tiers companies catalyst, clinical lead, insider lead, or watch. An advancing asset plus insiders buying.